CTSH Stock Recent News

Investors interested in stocks from the Computers - IT Services sector have probably already heard of Cognizant (CTSH) and Epam (EPAM). But which of these two stocks presents investors with the better value opportunity right now?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Award recognizes high-impact collaboration helping global clients navigate complex data landscapes and accelerate AI readiness at scale TEANECK, N.J. , June 4, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has been named Global Data Cloud Services Implementation Partner of the Year by Snowflake, the AI Data Cloud company, at Snowflake's annual user conference, Snowflake Summit 2025.

TEANECK, N.J. , June 4, 2025 /PRNewswire/ --  Cognizant  (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at the following investor conference:  Nasdaq Investor Conference in Partnership with Jefferies Presenter: Jatin Dalal, Chief Financial Officer Date: Wednesday, June 11, 2025  Time: 2:00PM GMT | 9:00 AM EDT   A live audio webcast of the presentation will be available at Cognizant's website: http://investors.cognizant.com   A replay of the webcasts will remain available on the company's website for 90 days.

TEANECK, N.J. , June 2, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has been named Partner of the Year by Pegasystems, Inc., a global leader in enterprise software, at the annual PegaWorld 2025 conference.

Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock?

TEANECK, N.J. , May 28, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at the following investor conference:  Bank of America Securities 2025 Global Technology Conference Presenter:  Surya Gummadi, President, Americas Date: Wednesday, June 4, 2025  Time: 2:00PM PST | 5:00PM EDT   A live audio webcast of the presentation will be available at Cognizant's website:  http://investors.cognizant.com   A replay of the webcasts will remain available on the company's website for 90 days.

Cognizant gains from strong AI advancements and key partnerships, positioning the company for strong growth.

Market Growth Driven by Increasing Demand for Real-World Evidence in Drug Development, Rising Focus on Value-Based Healthcare, Growing Cancer Incidence Globally, and Advancements in Data Analytics and AI Technologies REDDING, Calif., May 27, 2025 /PRNewswire/ -- According to a new market research report titled 'RWE Oncology Solutions Market by Component (Datasets, Consulting Services), Application (Drug Development & Approvals, Market Access & Reimbursement/Coverage Decisions, Medical Device Development & Approvals, Post-market Surveillance), End User, and Geography - Global Forecast to 2035', the RWE oncology solutions market is projected to reach $3.51 billion by 2035, up from an estimated $893 million in 2025, growing at a CAGR of 14.7% during the forecast period. The growth of this market is mainly driven by increasing demand for real-world evidence in drug development, rising focus on value-based healthcare, growing cancer incidence and prevalence globally, regulatory support for